Skip to main content

Table 1 Discounts by benefit categories and indication class

From: Benefit assessment in Germany: implications for price discounts

Additional benefit: overall      
Indication class by ICD-10 n Mean Min Max SD
Certain infectious and parasitic diseases 51 22.01 0.00 42.54 12.00
Diseases of the blood and blood-forming organs 2 24.50 23.15 25.85 1.91
Diseases of the circulatory system 14 25.25 4.65 58.73 16.10
Diseases of the digestive system 6 27.42 14.87 31.02 6.52
Diseases of the eye and adnexa 7 19.46 3.06 78.02 26.57
Diseases of the genitourinary system 2 19.80 19.80 19.80 0.00
Diseases of the musculoskeletal system and connective tissue 1 39.44 39.44 39.44
Diseases of the nervous system 9 37.84 * 24.32 67.30 14.40
Diseases of the respiratory system 9 12.93 * 2.01 25.74 11.24
Diseases of the skin and subcutaneous tissue 1 42.75 42.75 42.75
Endocrine, nutritional and metabolic diseases 24 19.86 1.00 48.60 12.43
Mental and behavioral disorders 2 25.68 17.36 34.00 11.77
Neoplasms 57 20.01 0.00 53.71 11.16
Other 8 20.73 13.64 28.55 6.43
Overall a 193 21.96 0.00 78.02 13.14
Size of target population a (upper level) 193 122808 6 3253000 409065
Additional benefit: overall with additional benefit
Indication class by ICD-10 n Mean Min Max SD
Certain infectious and parasitic diseases 29 20.16 0.00 42.54 12.57
Diseases of the circulatory system 8 27.32 4.65 58.73 17.77
Diseases of the digestive system 2 20.21 14.87 25.54 7.54
Diseases of the eye and adnexa 1 15.43 15.43 15.43
Diseases of the genitourinary system 2 19.80 19.80 19.80 0.00
Diseases of the musculoskeletal system and connective tissue 1 39.44 39.44 39.44
Diseases of the nervous system 2 40.69 * 29.71 51.67 15.53
Diseases of the respiratory system 3 4.99 * 2.01 10.96 5.17
Endocrine, nutritional and metabolic diseases 11 14.11 1.00 25.31 7.60
Other 4 16.36 13.64 24.50 5.43
Neoplasms 37 20.09 4.74 46.44 9.66
Overall 100 19.98 0.00 58.73 11.81
Size of target population (upper level) 100 80418 6 2542810 302323
  1. Abbreviations: Min minimum, Max maximum, SD standard deviation
  2. All discounts presented in %
  3. *p < 0.05 compared to mean discount of the other indications
  4. aIncluding the assessment with major benefit